The present review aims to offer novel insights and methodologies for the prevention and treatment of neurological disorders with trace Se, providing a scientific basis for the development of innovative Sebased neuroprotectants to promote their clinical application against neurological diseases
New York
Cruz-Aguado R, Fernandez-Verdecia CI, Daz-Surez CM, Gonzalez-Monzon O, Antunez-Potashkina I, et al
Always consult healthcare professionals before making changes to medication or treatment plans
Both promote angiogenesis through different pathways (BPC-157 via VEGFR2-Akt-eNOS and TB-500 via VEGF/HIF-1a), potentially amplifying blood vessel formation beyond what either achieves alone
Loren Pickart first isolated and identified GHK-Cu in 1973, discovering that this peptide complex demonstrated wound healing properties far exceeding what either component achieved alone